Legend Biotech is a global biotechnology company dedicated to the treatment and potential cure of life-threatening diseases. Based in Somerset, New Jersey, the organization is engaged in the development of cutting-edge cell therapies, utilizing various technology platforms such as autologous and allogeneic chimeric antigen receptor T-cell therapies and natural killer (NK) cell-based immunotherapy. A key component of Legend Biotech's strategy is its global collaboration with Janssen, a pharmaceutical company under Johnson & Johnson, aimed at advancing the promising immunotherapy, ciltacabtagene autoleucel (cilta-cel), for the treatment of multiple myeloma. The company operates with a commitment to scientific integrity, collaboration, and inclusivity, fostering an environment where innovative solutions can thrive in the pursuit of improving patient outcomes and enhancing lives across the globe.